Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride Patent Expiration

Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride is Used for treating allergic rhinitis, respiratory allergies, nasal swelling, sinus congestion, and pressure in adults and children aged 12 and older. It was first introduced by Chattem Inc Dba Sanofi Consumer Healthcare in its drug Allegra-D 12 Hour Allergy And Congestion on Jan 24, 2011. Another drug containing Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride is Allegra-D 24 Hour Allergy And Congestion. 8 different companies have introduced drugs containing Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride.


Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride Patents

Given below is the list of patents protecting Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Allegra-d 24 Hour Allergy And Congestion US6613357 Osmotic device containing pseudoephedrine and an H1 antagonist Dec 25, 2020

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US6039974 Pharmaceutical composition for combination of piperidinoalkanol-decongestant Jul 31, 2018

(Expired)

Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion USRE39069 Multi-layered osmotic device May 29, 2018

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US6037353

(Pediatric)

Method of providing an antihistaminic effect in a hepatically impaired patient Sep 14, 2017

(Expired)

Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion US6037353

(Pediatric)

Method of providing an antihistaminic effect in a hepatically impaired patient Sep 14, 2017

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient Mar 14, 2017

(Expired)

Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient Mar 14, 2017

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US5855912

(Pediatric)

Pharmaceutical compositions for piperidinalkanol compounds Aug 28, 2015

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US6113942

(Pediatric)

Pharmaceutical composition for piperidinoalkanol compounds Aug 28, 2015

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US5855912 Pharmaceutical compositions for piperidinalkanol compounds Feb 28, 2015

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US6113942 Pharmaceutical composition for piperidinoalkanol compounds Feb 28, 2015

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US7135571

(Pediatric)

Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof Nov 18, 2014

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US7138524

(Pediatric)

Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof Nov 18, 2014

(Expired)

Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion US7138524

(Pediatric)

Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof Nov 18, 2014

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US5578610

(Pediatric)

Piperidine derivatives May 26, 2014

(Expired)

Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion US5578610

(Pediatric)

Piperidine derivatives May 26, 2014

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof May 18, 2014

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof May 18, 2014

(Expired)

Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof May 18, 2014

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US5578610 Piperidine derivatives Nov 26, 2013

(Expired)

Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion US5578610 Piperidine derivatives Nov 26, 2013

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US6187791

(Pediatric)

Method of providing an antihistaminic effect in a hepatically impaired patient Nov 11, 2012

(Expired)

Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion US6399632

(Pediatric)

Method of providing an antihistaminic effect in a hepatically impaired patient Nov 11, 2012

(Expired)

Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion US6187791

(Pediatric)

Method of providing an antihistaminic effect in a hepatically impaired patient Nov 11, 2012

(Expired)

Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion US6399632

(Pediatric)

Method of providing an antihistaminic effect in a hepatically impaired patient Nov 11, 2012

(Expired)

Chattem Sanofi



Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride. The first generic version for Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride was by Barr Laboratories Inc and was approved on Apr 14, 2005. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Apr 17, 2025.

Given below is the list of companies who have filed for Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.